What's the Problem?
This recall affects Lot # 001211197, Exp. 12/25 of Lipodrene w/25mg Ephedra Extract Dietary Supplement, according to the U.S. Food & Drug Administration (FDA).
"The FDA has warned that DMAA is dangerous because it can narrow blood vessels and arteries and cause a corresponding rise in blood pressure or other cardiovascular problems, such as: Shortness of breath, Arrhythmias, Elevated blood pressure, Tightening in the chest, and Heart attack," the agency said.
This recall was initiated after an FDA analysis found the presence of DMAA in 1 lot of Lipodrene. The supplements were purchased by and distributed through wholesale and direct sales in the U.S. and Puerto Rico, and through online sales for both personal use and retail sales.
If you purchased any dietary supplements that are affected by this recall, you should not take them, and either throw them away or return them to the point of purchase for a refund.
This recall began on May 12, 2022.
Do I Have a Lipodrene Lawsuit?
The Products Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Lipodrene Lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
If you or another loved one was harmed by the side effects of Lipodrene, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.